866531-18-2

Upstream product

• 866531-15-9 4-Butyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid methyl ester 
• 39815-78-6 methyl 3-oxoheptanoate 
• 72505-21-6 4-trifluoromethylbenzthioamide 
• 866531-16-0 2-Chloro-3-oxo-heptanoic acid methyl ester 
• 866531-17-1 [4-Butyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-yl]-methanol 

Downstream Products

• 866531-28-4 3-{3-[4-butyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-propionic acid methyl ester 
• 866531-25-1 {4-[4-butyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-acetic acid methyl ester 
• 879982-22-6 1-[4-butyl-2-(4-(trifluoromethyl)-phenyl)-thiazol-5-ylmethyl]-5-methoxy-1H-pyrrolo[2,3-b]pyridine 
• 866531-19-3 4-[4-butyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-2-chloro-benzoic acid methyl ester 

Relevant academic research and scientific papers

7-AZAINDOLES AND THEIR USE AS PPAR AGONISTS

The invention relates to 7-azaindoles and to their physiologically acceptable salts and physiologically functional derivatives showing PPAR agonist activity. What is described are compounds of the formula I, in which the radicals are as defined, and their

1,3,4-OXADIAZOL-2-ONES AS PPAR DELTA MODULATORS AND THEIR USE THEREOF

The present invention is directed to 1, 3, 4-oxadiazolones, compounds of formula (I) and their pharmaceutically acceptable salts stereoisomers, tautomers, or solvates thereof. Novel compounds include those of formula (I), in which radicals are as defined

Oxadiazolones, processes for their preparation and their use as pharmaceuticals

The invention relates to oxadiazolones and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. What is described are compounds of the formula I, in which the radicals are as defined, and